Skip to content

Open Systems Pharmacology PBPK Model Library

Physiologically Based Pharmacokinetic (PBPK) and Quantitative Systems Pharmacology (QSP) Modeling Platform

This comprehensive library provides PBPK (Physiologically Based Pharmacokinetic) models and detailed model evaluation reports from the Open Systems Pharmacology project. Our PBPK and QSP modeling and simulation software (including PK-Sim® and MoBi®) enables whole-body physiologically based pharmacokinetic modeling for pharmaceutical research, drug development, and systems biology applications.

How to Use These Models

Each PBPK model in this library includes:

  • HTML Report: Comprehensive evaluation report with pharmacokinetic modeling details, validation data, and simulation results
  • PDF Report: Downloadable model evaluation report for offline reference
  • PK-Sim Project Files (.pksim5): Ready-to-use model files that can be opened directly in PK-Sim®

These models are built using the Open Systems Pharmacology Suite and can be used for e.g.:

  • Drug-drug interaction (DDI) predictions
  • Dose optimization and scaling across populations
  • Pediatric and special population modeling

Available PBPK Models and Evaluation Reports

Antibiotics

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Amikacin Amikacin_evaluation_report.pdf Amikacin-Model.pksim5 Amikacin-Pediatrics.pksim5
Clarithromycin Clarithromycin_evaluation_report.pdf Clarithromycin-Model.pksim5
Erythromycin Erythromycin_evaluation_report.pdf Erythromycin-Model.pksim5
Ethinylestradiol Ethinylestradiol_evaluation_report.pdf Ethinylestradiol-Model.pksim5
Rifampicin Rifampicin_evaluation_report.pdf Rifampicin-Model.pksim5
Vancomycin Vancomycin_evaluation_report.pdf Vancomycin-Pediatrics.pksim5 Vancomycin.pksim5

Antivirals

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Atazanavir Atazanavir_evaluation_report.pdf Atazanavir-Model.pksim5
Efavirenz Efavirenz_evaluation_report.pdf Efavirenz-Model.pksim5
Raltegravir Raltegravir_evaluation_report.pdf Raltegravir-Model.pksim5 Raltegravir-Pediatrics.pksim5

Antifungals

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Omeprazole Omeprazole_evaluation_report.pdf Omeprazole-Model.pksim5

Anesthetics & Analgesics

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Alfentanil Alfentanil_evaluation_report.pdf Alfentanil-Model.pksim5 Alfentanil-Pediatrics.pksim5
Sufentanil Sufentanil_evaluation_report.pdf Sufentanil-Pediatrics.pksim5 Sufentanil.pksim5

Sedatives & Anxiolytics

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Alprazolam Alprazolam_evaluation_report.pdf Alprazolam-Model.pksim5
Midazolam Midazolam_evaluation_report.pdf Midazolam-Model.pksim5
Triazolam Triazolam_evaluation_report.pdf Triazolam-Model.pksim5

Anticonvulsants

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Carbamazepine Carbamazepine_evaluation_report.pdf Carbamazepine-Model.pksim5
S-Mephenytoin S-Mephenytoin_evaluation_report.pdf S_Mephenytoin-Model.pksim5

Cardiovascular Agents

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Cimetidine Cimetidine_evaluation_report.pdf Cimetidine-Model.pksim5
Dapagliflozin Dapagliflozin_evaluation_report.pdf Dapagliflozin-Model.pksim5
Digoxin Digoxin_evaluation_report.pdf Digoxin-Model.pksim5 Digoxin_Pediatrics.pksim5
Felodipine Felodipine_evaluation_report.pdf Felodipine-Model.pksim5
Fluconazole Fluconazole_evaluation_report.pdf Fluconazole-Model.pksim5
Itraconazole Itraconazole_evaluation_report.pdf Itraconazole-Model.pksim5
Mefenamic_acid Mefenamic_acid_evaluation_report.pdf Mefenamic_acid-Model.pksim5
Mexiletine Mexiletine_evaluation_report.pdf Mexiletine-Model.pksim5
Montelukast Montelukast_evaluation_report.pdf Montelukast-Pediatrics.pksim5 Montelukast.pksim5
Propofol Propofol_evaluation_report.pdf Propofol-Pediatrics.pksim5 Propofol.pksim5
Sildenafil Sildenafil_evaluation_report.pdf Sildenafil-Model.pksim5
Verapamil Verapamil_evaluation_report.pdf Verapamil-Model.pksim5

Antibodies & Biologics

Compound (HTML Report) PDF Report PK-Sim Project File(s)
7E3 7E3_evaluation_report.pdf 7E3.pksim5
BAY794620 BAY794620_evaluation_report.pdf BAY794620.pksim5
CDA1 CDA1_evaluation_report.pdf CDA1.pksim5
dAb2 dAb2_evaluation_report.pdf dAb2.pksim5
Inulin Inulin_evaluation_report.pdf Inulin.pksim5
MEDI524 MEDI524_evaluation_report.pdf MEDI524.pksim5
MEDI524YTE MEDI524YTE_evaluation_report.pdf MEDI524YTE.pksim5
Tefibazumab Tefibazumab_evaluation_report.pdf Tefibazumab.pksim5

Other Compounds

Compound (HTML Report) PDF Report PK-Sim Project File(s)
Fluvoxamine Fluvoxamine_evaluation_report.pdf Fluvoxamine-Model.pksim5
Moclobemide Moclobemide_evaluation_report.pdf Moclobemide-Model.pksim5
Tizanidine Tizanidine_evaluation_report.pdf Tizanidine-Model.pksim5

Frequently Asked Questions (FAQ)

What is a PBPK model?

A Physiologically Based Pharmacokinetic (PBPK) model is a mathematical model that predicts the absorption, distribution, metabolism, and excretion (ADME) of drugs in the body. PBPK models incorporate anatomical, physiological, and biochemical information to simulate drug concentration-time profiles in various tissues and organs.

How do I open a .pksim5 file?

.pksim5 files are PK-Sim project files that can be opened with the PK-Sim® software, part of the Open Systems Pharmacology Suite. Download PK-Sim for free from www.open-systems-pharmacology.org. After installation, simply double-click the .pksim5 file or open it from within PK-Sim.

Are these models validated?

Yes, all models in this library have undergone comprehensive evaluation. Each model includes detailed evaluation reports documenting the validation against clinical pharmacokinetic data, including goodness-of-fit assessments and predictive performance metrics.

How can I cite these models?

Each model page includes specific citation information in the evaluation report. In general, please cite the Open Systems Pharmacology project and the specific model evaluation report. Additional details can be found on the Open Systems Pharmacology website.

What software do I need?

To use these models, you'll need the Open Systems Pharmacology Suite, which includes:

  • PK-Sim®: For PBPK modeling and simulation
  • MoBi®: For more advanced mechanistic modeling (optional)

Both tools are free and open-source, available at www.open-systems-pharmacology.org.